Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Inventory (2018 - 2025)

Sunshine Biopharma (SBFM) has disclosed Change in Inventory for 8 consecutive years, with $1.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Inventory rose 2.66% year-over-year to $1.3 million, compared with a TTM value of $4.2 million through Sep 2025, down 21.16%, and an annual FY2024 reading of $6.0 million, up 153.93% over the prior year.
  • Change in Inventory was $1.3 million for Q3 2025 at Sunshine Biopharma, up from $555075.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $2.1 million in Q1 2024 and bottomed at -$206974.0 in Q4 2022.
  • Average Change in Inventory over 5 years is $569546.4, with a median of $417318.0 recorded in 2023.
  • Peak annual rise in Change in Inventory hit 2456.77% in 2022, while the deepest fall reached 702.72% in 2022.
  • Year by year, Change in Inventory stood at $34340.0 in 2021, then tumbled by 702.72% to -$206974.0 in 2022, then soared by 652.94% to $1.1 million in 2023, then surged by 57.71% to $1.8 million in 2024, then dropped by 28.74% to $1.3 million in 2025.
  • Business Quant data shows Change in Inventory for SBFM at $1.3 million in Q3 2025, $555075.0 in Q2 2025, and $568834.0 in Q1 2025.